Search results for "Statins"
Telmisartan does not improve walking performance in PAD
A randomized double-blind trial compared the angiotensin-receptor blocker with placebo in patients with peripheral artery disease (PAD) and found no difference in six-minute walk distance over six months.
https://immattersacp.org/weekly/archives/2022/10/11/2.htm
11 Oct 2022
3 common drugs associated with reduced risk of hospitalization and harm in serious mental illness
Statins, calcium-channel blockers, and metformin are globally licensed, commonly used, inexpensive, and relatively safe, and therefore “ideal candidates for repurposing” for mental illness, the study authors wrote.
https://immattersacp.org/weekly/archives/2019/01/15/4.htm
15 Jan 2019
Know the patient to achieve statin benefits
That statins work is without question. And with costs falling due to many drugs in the class going generic, physicians are now refining when to prescribe the ubiquitous drug class based on the degree of risk.
https://immattersacp.org/archives/2010/11/statin.htm
1 Nov 2010
MKSAP Quiz: 4-week history of lower extremity weakness
A 52-year-old man is evaluated for 4-week history of left lower extremity weakness that began with tripping on the left foot. He now must lift his knee to clear his foot off the ground. He reports no pain but has mild tingling on the lateral border of his left foot. Following a physical exam, lab test, and electromyogram, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2022/01/18/3.htm
18 Jan 2022
Updated guideline on cholesterol management focuses on detailed risk assessment
The guideline from the American College of Cardiology/American Heart Association recommends that physicians talk to patients about risk-enhancing factors that can help provide a more personalized risk assessment, in addition to such traditional risk factors as smoking and high blood pressure.
https://immattersacp.org/weekly/archives/2018/11/20/2.htm
20 Nov 2018
Warning about mixing protease inhibitors with statins
This regulatory update includes a warning on combining protease inhibitors and statins, approval of an orphan drug, and steps the FDA is taking to increase the supply of cancer drugs.
https://immattersacp.org/archives/2012/05/fda.htm
1 May 2012
Adding colchicine after MI may reduce cardiovascular events
While a trial found that low-dose colchicine reduced cardiovascular events after myocardial infarction (MI) significantly more than placebo, there are unresolved questions about inflammation as a therapeutic target, an accompanying editorial noted.
https://immattersacp.org/weekly/archives/2019/11/26/1.htm
26 Nov 2019
Calculating risk for cholesterol drugs
Differing guidelines and a new class of drugs may cause uncertainty on the part of patients and practitioners.
https://immattersacp.org/archives/2015/11/cholesterol.htm
1 Nov 2015
Studies of LDL levels, therapies support treatment of those older than age 70
A retrospective study found the association between low-density lipoprotein (LDL) cholesterol levels and cardiovascular events to increase with age, while a meta-analysis highlighted the benefits of statins and other lipid-lowering therapies in older patients.
https://immattersacp.org/weekly/archives/2020/11/17/4.htm
17 Nov 2020
Lipophilic statins associated with significantly reduced hepatocellular carcinoma incidence, mortality in hepatitis
Potential benefits of lipophilic statins appeared to be dose- and duration-dependent, with the greatest reduction in hepatocellular carcinoma risk seen with use of a moderate-dose statin for about two years, according to data from a registry of Swedish patients with hepatitis B or C.
https://immattersacp.org/weekly/archives/2019/08/20/1.htm
20 Aug 2019